An Observational Study to Assess the Effect of Cumulative Ribavirin Dose in Participants With Chronic Hepatitis C
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this open-label, non-randomized, single-arm, multicentre observational study
is to investigate the influence of the cumulative dose (total administered dose/ planned
dose) of ribavirin on the sustained virologic response (SVR) in participants who have been
receiving combination therapy with pegylated interferon alfa-2a (Pegasys) and ribavirin
(Copegus).